The National Cancer Institute funds systematic evaluations of scientific evidence on carcinogenic hazards to humans to inform cancer research, control, and prevention; clinical trials are not allowed.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
NIH supports basic research on how toxic chemicals injure skin to spur discovery and early development of broad-spectrum medical countermeasures; clinical trials are not allowed.
The National Cancer Institute funds cancer epidemiology cohort research on cancer causes and survivorship, including cohort upkeep, follow-up, and data and biospecimen sharing; clinical trials are not allowed.
Explore existing data to uncover cancer risk insights, seeking to understand outcomes like survival and treatment response.
Grant supports research on skin injuries caused by chemical threats, aiming to identify commonalities for medical countermeasure development.